|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katai H, Ishikawa T, Akazawa K, Isobe Y,
Miyashiro I, Oda I, Tsujitani S, Ono H, Tanabe S, Fukagawa T, et
al: Five-year survival analysis of surgically resected gastric
cancer cases in Japan: A retrospective analysis of more than
100,000 patients from the nationwide registry of the Japanese
gastric cancer association (2001–2007). Gastric Cancer. 21:144–154.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng PL, Zhou XY, Yi GD, Chen PF, Wang F
and Dong WG: Identification of a novel gene pairs signature in the
prognosis of gastric cancer. Cancer Med. 7:344–350. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pankov R and Yamada KM: Fibronectin at a
glance. J Cell Sci. 115:3861–3863. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Plow EF, Haas TA, Zhang L, Loftus J and
Smith JW: Ligand binding to integrins. J Biol Chem.
275:21785–21788. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Korah R, Boots M and Wieder R: Integrin
alpha5beta1 promotes survival of growth-arrested breast cancer
cells: An in vitro paradigm for breast cancer dormancy in bone
marrow. Cancer Res. 64:4514–4522. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xiao J, Yang W, Xu B, Zhu H, Zou J, Su C,
Rong J, Wang T and Chen Z: Expression of fibronectin in esophageal
squamous cell carcinoma and its role in migration. BMC Cancer.
18:9762018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai X, Liu C, Zhang TN, Zhu YW, Dong X and
Xue P: Down-regulation of FN1 inhibits colorectal
carcinogenesis by suppressing proliferation, migration, and
invasion. J Cell Biochem. 119:4717–4728. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nakagawa Y, Nakayama H, Nagata M, Yoshida
R, Kawahara K, Hirosue A, Tanaka T, Yuno A, Matsuoka Y, Kojima T,
et al: Overexpression of fibronectin confers cell adhesion-mediated
drug resistance (CAM-DR) against 5-FU in oral squamous cell
carcinoma cells. Int J Oncol. 44:1376–1384. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang J, Deng L, Huang J, Cai R, Zhu X, Liu
F, Wang Q, Zhang J and Zheng Y: High expression of fibronectin 1
suppresses apoptosis through the NF-κB pathway and is associated
with migration in nasopharyngeal carcinoma. Am J Transl Res.
9:4502–4511. 2017.PubMed/NCBI
|
|
12
|
Lou X, Han X, Jin C, Tian W, Yu W, Ding D,
Cheng L, Huang B, Jiang H and Lin B: SOX2 targets fibronectin 1 to
promote cell migration and invasion in ovarian cancer: New
molecular leads for therapeutic intervention. OMICS. 17:510–518.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Waalkes S, Atschekzei F, Kramer MW,
Hennenlotter J, Vetter G, Becker JU, Stenzl A, Merseburger AS,
Schrader AJ, Kuczyk MA and Serth J: Fibronectin 1 mRNA expression
correlates with advanced disease in renal cancer. BMC Cancer.
10:5032010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sponziello M, Rosignolo F, Celano M,
Maggisano V, Pecce V, De Rose RF, Lombardo GE, Durante C, Filetti
S, Damante G, et al: Fibronectin-1 expression is increased in
aggressive thyroid cancer and favors the migration and invasion of
cancer cells. Mol Cell Endocrinol. 431:123–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xu TP, Huang MD, Xia R, Liu XX, Sun M, Yin
L, Chen WM, Han L, Zhang EB, Kong R, et al: Decreased expression of
the long non-coding RNA FENDRR is associated with poor prognosis in
gastric cancer and FENDRR regulates gastric cancer cell metastasis
by affecting fibronectin1 expression. J Hematol Oncol. 7:632014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Sun Z, Li Y, Fan D and Jiang H:
MicroRNA-200c binding to FN1 suppresses the proliferation,
migration and invasion of gastric cancer cells. Biomed
Pharmacother. 88:285–292. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Chin-Sheng H, Kuo LJ, Wei PL, Lien
YC, Lin FY, Liu HH, Ho YS, Wu CH and Chang YJ: NNK enhances cell
migration through alpha7-nicotinic acetylcholine receptor
accompanied by increased of fibronectin expression in gastric
cancer. Ann Surg Oncol. 19 (Suppl):S580–S588. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon
SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression
signature-based prognostic risk score in gastric cancer. Clin
Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
D'Errico M, de Rinaldis E, Blasi MF, Viti
V, Falchetti M, Calcagnile A, Sera F, Saieva C, Ottini L, Palli D,
et al: Genome-wide expression profile of sporadic gastric cancers
with microsatellite instability. Eur J Cancer. 45:461–469. 2009.
View Article : Google Scholar
|
|
20
|
Kim HK, Choi IJ, Kim CG, Kim HS, Oshima A,
Michalowski A and Green JE: A gene expression signature of acquired
chemoresistance to cisplatin and fluorouracil combination
chemotherapy in gastric cancer patients. PLoS One. 6:e166942011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ooi CH, Ivanova T, Wu J, Lee M, Tan IB,
Tao J, Ward L, Koo JH, Gopalakrishnan V, Zhu Y, et al: Oncogenic
pathway combinations predict clinical prognosis in gastric cancer.
PLoS Genet. 5:e10006762009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chia NY, Deng N, Das K, Huang D, Hu L, Zhu
Y, Lim KH, Lee MH, Wu J, Sam XX, et al: Regulatory crosstalk
between lineage-survival oncogenes KLF5, GATA4 and GATA6
cooperatively promotes gastric cancer development. Gut. 64:707–719.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lei Z, Tan IB, Das K, Deng N, Zouridis H,
Pattison S, Chua C, Feng Z, Guan YK, Ooi CH, et al: Identification
of molecular subtypes of gastric cancer with different responses to
PI3-kinase inhibitors and 5-fluorouracil. Gastroenterology.
145:554–565. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Muratani M, Deng N, Ooi WF, Lin SJ, Xing
M, Xu C, Qamra A, Tay ST, Malik S, Wu J, et al: Nanoscale chromatin
profiling of gastric adenocarcinoma reveals cancer-associated
cryptic promoters and somatically acquired regulatory elements. Nat
Commun. 5:43612014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He J, Jin Y, Chen Y, Yao HB, Xia YJ, Ma
YY, Wang W and Shao QS: Downregulation of ALDOB is associated with
poor prognosis of patients with gastric cancer. Onco Targets Ther.
9:6099–6109. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tao J, Deng NT, Ramnarayanan K, Huang B,
Oh HK, Leong SH, Lim SS, Tan IB, Ooi CH, Wu J, et al: CD44-SLC1A2
gene fusions in gastric cancer. Sci Transl Med. 3:77ra302011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee J, Sohn I, Do IG, Kim KM, Park SH,
Park JO, Park YS, Lim HY, Sohn TS, Bae JM, et al: Nanostring-based
multigene assay to predict recurrence for gastric cancer patients
after surgery. PLoS One. 9:e901332014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li WQ, Hu N, Burton VH, Yang HH, Su H,
Conway CM, Wang L, Wang C, Ding T, Xu Y, et al: PLCE1 mRNA and
protein expression and survival of patients with esophageal
squamous cell carcinoma and gastric adenocarcinoma. Cancer
Epidemiol Biomarkers Prev. 23:1579–1588. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang Q, Wen YG, Li DP, Xia J, Zhou CZ, Yan
DW, Tang HM and Peng ZH: Upregulated INHBA expression is associated
with poor survival in gastric cancer. Med Oncol. 29:77–83. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang G, Hu N, Yang HH, Wang L, Su H, Wang
C, Clifford R, Dawsey EM, Li JM, Ding T, et al: Comparison of
global gene expression of gastric cardia and noncardia cancers from
a high-risk population in china. PLoS One. 8:e638262013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu Y, Grabsch H, Ivanova T, Tan IB, Murray
J, Ooi CH, Wright AI, West NP, Hutchins GG, Wu J, et al:
Comprehensive genomic meta-analysis identifies intra-tumoural
stroma as a predictor of survival in patients with gastric cancer.
Gut. 62:1100–1111. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sung CO, Park CK and Kim SH:
Classification of epithelial-mesenchymal transition phenotypes in
esophageal squamous cell carcinoma is strongly associated with
patient prognosis. Mod Pathol. 24:1060–1068. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bae YK, Kim A, Kim MK, Choi JE, Kang SH
and Lee SJ: Fibronectin expression in carcinoma cells correlates
with tumor aggressiveness and poor clinical outcome in patients
with invasive breast cancer. Hum Pathol. 44:2028–2037. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sandsmark E, Andersen MK, Bofin AM,
Bertilsson H, Drablos F, Bathen TF, Rye MB and Tessem MB: SFRP4
gene expression is increased in aggressive prostate cancer. Sci
Rep. 7:142762017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Washington K: 7th edition of the AJCC
cancer staging manual: Stomach. Ann Surg Oncol. 17:3077–3079. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Morita Y, Hata K, Nakanishi M, Omata T,
Morita N, Yura Y, Nishimura R and Yoneda T: Cellular fibronectin 1
promotes VEGF-C expression, lymphangiogenesis and lymph node
metastasis associated with human oral squamous cell carcinoma. Clin
Exp Metastasis. 32:739–753. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sengupta S, Nandi S, Hindi ES, Wainwright
DA, Han Y and Lesniak MS: Short hairpin RNA-mediated fibronectin
knockdown delays tumor growth in a mouse glioma model. Neoplasia.
12:837–847. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hanamura N, Yoshida T, Matsumoto E,
Kawarada Y and Sakakura T: Expression of fibronectin and tenascin-C
mRNA by myofibroblasts, vascular cells and epithelial cells in
human colon adenomas and carcinomas. Int J Cancer. 73:10–15. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Soikkeli J, Podlasz P, Yin M, Nummela P,
Jahkola T, Virolainen S, Krogerus L, Heikkila P, von Smitten K,
Saksela O and Hölttä E: Metastatic outgrowth encompasses COL-I,
FN1, and POSTN up-regulation and assembly to fibrillar
networks regulating cell adhesion, migration, and growth. Am J
Pathol. 177:387–403. 2010. View Article : Google Scholar : PubMed/NCBI
|
